A股異動丨翔豐華(300890.SZ)漲超6% 擬新增投資18億元建8萬噸人造石墨負極材料一體化項目
格隆匯8月8日丨翔豐華(300890.SZ)漲超6%,報57.65元,總市值61億元。公司與蓬溪縣人民政府於2021年5月28日簽訂了《投資協議》,雙方約定投資12億元,用地400畝左右,建設“翔豐華6萬噸高端人造石墨負極材料一體化生產基地建設項目”。經雙方友好協商,在原投資協議基礎上,公司擬追加投資建設,與甲方簽署《追加投資協議》。原協議投資建設項目稱為一期項目,根據本協議新增投資建設項目“翔豐華8萬噸人造石墨負極材料一體化項目”稱為二期項目。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.